President Donald Trump struck a second deal last month with the world’s largest drugmakers, promising lower costs for American patients. The industry claims cooperation, offering help for consumers and expanded domestic production. Yet those same companies have raised prices on nearly 700 prescription drugs since January.

Big Pharma hopes the most unconventional president will fall back on the most conventional policy: granting the largest firms regulatory advantages, taxpayer-funded promotion, and freedom to keep ratcheting prices upward.

Trump should expose the game Big Pharma has played for years and force the industry to compete in a real marketplace.

Trump’s instincts are right. Americans pay inflated prices, and he has confronted the industry’s excesses. But Big Pharma spent decades building cartel-level dominance. Few industries mastered regulatory capture more effectively. The pharma industry wins higher prices while concealing the system that keeps costs rising.

The industry’s tactics follow a predictable pattern. With its right hand, Big Pharma announces a partnership with the White House. With its left, it secures guaranteed government contracts, political protection, and federally promoted products. Independent analysts warn that rebate schemes encourage price hikes. The dynamic mirrors a retailer inflating list prices before Black Friday to create the illusion of deep discounts.

The federal government helps tip the scales. Regulatory frameworks favor the largest drugmakers and block smaller competitors, keeping profits high and patients in the dark.

Patients pay the price

What the industry calls reform resembles a shell game that protects profits and punishes patients. The Food and Drug Administration created an “accelerated approval” pathway to speed lifesaving treatments. In practice, the system advantages the largest corporations. A 2020 study found that increases in FDA regulations boosted sales for major firms while cutting sales for smaller companies by 2.2%. Smaller manufacturers cannot absorb substantial compliance costs, which means cheaper or more effective drugs never reach the market or arrive years late.

Patients pay the price. Follow-up studies for expedited approvals lag for years, and many drugs never show clear benefits. Harvard researchers found that nearly half of cancer drugs granted accelerated approval fail to improve survival or quality of life. The FDA withdrew one in four such drugs and confirmed substantial benefit for only 12% of the rest. The drugs generated revenue, but they offered little hope to patients who paid dearly for treatments that did not deliver.

RELATED: The hidden hospital scam driving up drug prices, coming to a state near you

Deagreez via iStock/Getty Images

Meanwhile, prices keep climbing. Since Trump left office after his first term, cancer drug prices rose faster than Biden-era inflation. Median list prices for new medicines more than doubled between 2021 and 2024, surpassing $300,000 a year. In 2023 alone, drug companies raised prices by 35%. The Rand Corporation found that Americans spent more than $600 billion on prescriptions in 2022 — almost triple what patients in other developed nations pay.

Competition, not cronyism

Families facing cancer now shoulder thousands more out of pocket while Big Pharma posts record profits. Trump deserves credit for recognizing how unfair practices and Democrat policies pushed drug costs beyond the reach of average households.

A better path is within reach. Real reform depends on competition rather than political connections. Trump can break the illusion by opening the market, lowering barriers to entry, and cutting regulatory burdens that keep smaller firms out. He should expose the game Big Pharma has played for years and force the industry to compete in a real marketplace.

​Opinion & analysis, Donald trump, Big pharma, Prescription costs, Prescription drugs, Health insurance, Hospitals, Regulatory capture, Food and drug administration, Fda, Black friday, Profits, Free markets, Economics, Regulations, Compliance, Competition 

Everybody has a diagnosis these days.

Not just adults — kids too. It doesn’t matter if you’re 8 or 38, there’s someone somewhere waiting to explain away whatever’s different about you.

Perhaps you find your work excruciatingly boring and hard to care about precisely because it is excruciatingly boring and hard to care about.

It’s not a quirk of your personality or a flaw in your character or a wound in your soul. It’s a illness. Never mind that the symptoms are vague or the evidence that it’s a discrete medical condition are lacking — a pharmaceutical cure will fix it.

Just pop this pill, and you will be like everyone else. Isn’t that what you want?

All the rage

All the kids these days have ADHD or autism. Which often makes me wonder if any of them do. Or if these conditions exist at all.

Autism certainly seems real in its extreme forms, but I am not at all convinced that it’s at the far end of a continuum. I don’t really think being a little “on the spectrum” is a thing. Those people are just a little weird and need stronger guidance on how to get on in life.

I have a friend who was an engineer at Google. He told me half the people he worked with claimed to be “on the spectrum,” and according to him, it was all bull. They didn’t have medical problems; they had personal problems. They were guys who never learned how to interact normally, so they just ended up being kind of weird and rude.

As for ADHD, it’s so obscenely overdiagnosed that it’s essentially fake at this point. The market has been so oversaturated by ridiculous and erroneous diagnoses that whenever I hear about another kid with ADHD, it tells me more about the doctors and the “system” and less about the kid.

Boys will be boys

Are some kids better at sitting down at a desk for three hours at a time? Sure. Are more girls than boys better at doing it? Yes. Is there a gender factor here when it comes to diagnosis? Absolutely.

Boys don’t learn the same way girls do. But much of modern education ignores this fact. So when boys fidget or get bored, it gets chalked up to ADHD. This is more or less common knowledge by now. So the only thing a boy being diagnosed with ADHD tells me is that he doesn’t get enough recess.

Of course, there are extreme cases. There are kids who genuinely don’t seem to be able to focus at all. Something like actual ADHD exists in a small number of boys, but that doesn’t negate the broader truth: Instead of seeing people as individuals with different strengths and weaknesses, we decide to overmedicate when someone isn’t exactly like everyone else.

My mom worked with special ed kids. Some of them had mild disabilities, some more extreme. In some cases, it was clear they would need supervised care their entire lives. But in other cases, it wasn’t clear just what, if anything, was wrong — besides a certain learned helplessness reinforced by doctors and parents.

Pill and chill

Nowadays ADHD diagnoses aren’t just for kids; adults are getting in on it too. Believe it or not, an increasing amount of men and women, especially women, in their 30s and 40s are discovering that they too have ADHD — a discovery that inevitably “explains everything.” My wife sees reels on Instagram all the time, along with ads selling various solutions.

What’s that? You couldn’t focus at your computer, clicking on an excel spreadsheet, sending pointless emails for seven hours at a time? Shocking. No, you don’t need ADHD medication. You need to do something else with your life. Perhaps you find your work excruciatingly boring and hard to care about precisely because it is excruciatingly boring and hard to care about.

Overmedicalization and overdiagnosis is a deep problem in our society. Not just because the result is an increase in prescription drug use, but because the individual human being is lost or suffocated a little bit at a time. Everyone is different. Everyone has skills, and everyone has weaknesses. Everyone learns in a different way, and everyone focuses on different things too.

RELATED: Drugged for being boys: The TRUTH behind the ADHD scam

Blaze Media

Free agency

Some people are just a little awkward, a little weird, a little absent-minded, or a little dry. Sure, they should try to meet society halfway in some reasonable sense — but that happens through early teaching, parental guidance, community expectations, and personal effort, not through a pill you pop every day. For most of the 20th century, we relied far more on those nonmedical supports.

All the pill-popping flattens our individualism and undercuts our own agency as humans. It presupposes that one cannot make oneself better, one cannot work to act right, and that one doesn’t have any control. This is a lie. Yes, of course, there are people who suffer with truly debilitating problems who need medication, and they should get that medication. But it is a small fraction of the population. Most people can make themselves better when they set their minds to it.

Don’t get me wrong. I’m not anti-psychiatry. I’m not into alternative medicine or any of the hippie stuff. I’m not denying that there are people with problems who are helped most effectively with medication. I’m thankful for the blessings of modern medicine and the advancements we continue to see every year.

But we have a problem with overdiagnosis in our country. We have a problem with losing sight of the individual. We have a problem with people who want to give up their agency and turn it all over to a pill, and we are worse off because of it.

​Men’s style, Family, Lifestyle, Health, Adhd, Autism, Big pharma, Pharmaceuticals, Fatherhood, The root of the matter 

Antifa radicals have been causing chaos throughout America for years and have finally been designated as a terrorist network by the Trump administration.

However, they’re still getting away with crimes.

“Antifa radicals in Berkeley, California, disrupted a Turning Point USA event outside of UC Berkeley, punched a conservative in the face. The conservative gets arrested,” BlazeTV host Christopher Rufo tells co-host Jonathan “Lomez” Keeperman on “Rufo & Lomez.”

“But our policy prescription is, the administration has to dismantle the left-wing terror networks, whether it’s Antifa, other organized militant groups. They have to actually get mugshots, case numbers, inmate numbers,” he continues.

“The tangible evidence that these left-wing terror networks, which are essentially saying that we can control the streets in places like Portland, we can veto peaceful conservative speech in places like Berkeley — we have to ensure that they can no longer do so and can no longer exert control through violence,” he adds.

While Rufo points out that Antifa is still out there disrupting whatever it can, Lomez notes that it was a “huge step in the right direction” that it has at least been designated as a terrorist network.

“The administration is making the right moves and/or saying the right things. What’s missing is the conspicuous action so that your average American, let alone Trump supporter, but just your average American goes, ‘Yeah, I don’t like Antifa, and the administration is doing something about it, and that’s good,’” Lomez says.

But the next step is taking the terrorist designation and doing something with it.

“Let’s just take this case at UC Berkeley, this recent event. The attorney general, Pam Bondi, released a great tweet,” Rufo says.

“Antifa is an existential threat to our nation. The violent riots at UC Berkeley last night are under full investigation by the FBI-led Joint Terrorism Task Force. We will continue to spare no expense unmasking all who commit and orchestrate acts of political violence,” Bondi wrote.

“Under President Trump’s leadership, and pursuant to his Executive Order designating Antifa as a domestic terror organization, the Department of Justice and our law-enforcement partners are dismantling violent networks that seek to intimidate Americans and suppress their free expression and First Amendment rights,” she added.

While Rufo is glad to see Bondi using such strong wording, he’s skeptical.

“Why hasn’t UC Berkeley been defunded? Just say, ‘Hey, we’re withholding funds until you can establish a basic environment of civil discourse,’” Rufo says.

“You have to make sure that the directive that comes from the, you know, FBI director’s office, the attorney general’s office, you have to make sure that it means something at that regional level, at that agent level,” he explains.

“And I am not convinced that the current leadership, that the current structure, the current techniques that they’re using has sufficiently done that,” he adds.

Want more from Rufo & Lomez?

To enjoy more of the news through the anthropological lens of Christopher Rufo and Lomez, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

​Video phone, Upload, Sharing, Camera phone, Free, Video, Youtube.com, Rufo & lomez, Chris rufo, The blaze, Blazetv, Blaze news, Blaze podcasts, Blaze podcast network, Blaze media, Blaze online, Blaze originals, Lomez, Antifa, Uc berkeley, Tpusa event, Terrorist designation, Left wing militant, Left wing violence